+44 (0)1494 614 659
info@avidnano.com



  NEWS

Avid Nano in Next Generation DLS Development Initiative
Avid Nano are to develop new technology for identification and size measurement of engineered nanoparticles in the environment. The company have joined a consortium of SMEs and the European Commission under the Seventh Framework Programme (FP7) in an effort to properly assess the fate and potential safety risks associated with engineered nanoparticles (ENPs) being increasingly deployed in such everyday things as paints, cosmetics, sunscreens, deodorants and medicines.  Read the full article.

 VIDEO FEATURE 

See for yourself how easy DLS has become by watching our NEW video.  Visit our Media section.

 INTERACTIVE FEATURE 

The W130i and BladeCell cuvettes can be up to 8x faster than traditional quartz cuvette based DLS.  Visit our Media section.

 NEXT EVENT 

We are exclusively sponsoring the London Structural Biology Club meeting at Birkbeck College, London, UK on July 3rd 2012.  Come and see the W130i and try it out with your own samples if you want.  We'll be there throughout the meeting.

 PRODUCT FEATURE

BladeCell™ disposable micro-cuvettes deliver the performance of a traditional quartz cuvette  with the economy and convenience of a true disposable.  The patent pending design utilizes a unique liquid trap to capture and retain the sample to a precisely defined profile suitable for analysis by dynamic light scattering.  It's like nothing ever before and it's only available from Avid Nanomore...

        


Testimonials


“Brilliant little machine.  In just one afternoon, we have seen more amount and quality of data than in the entire working life of the old instrument. I think everyone who sees the W130i in action would want to have one”.
Major Global Pharma R&D, UK.


“We are impressed by the user friendliness of the W130i. The most interesting feature of the system is the BladeCell disposable cuvettes which allows very simple manipulation yet still provides precise measurement results”.
Alexey Rak, Sanofi Aventis R&D, Paris.